PANCAID
@pancaid.bsky.social
290 followers 290 following 71 posts
PANCAID, acronym for PANcreatic CAncer Initial Detection via liquid biopsy, is a research consortium in #pancreaticcancer #PDAC Funded by the European Union. More info: https://www.pancaid-project.eu/
Posts Media Videos Starter Packs
Pinned
pancaid.bsky.social
Join our webinar “Approaches to Early Cancer Diagnosis and the Impact of Artificial Intelligence in Oncology”!
@phireproject.bsky.social, #PANCAIM & @pancaid.bsky.social are proud to discuss how AI is transforming #oncology.

🔗 Register: events.teams.microsoft.com/event/1fba7a...

#CancerResearch
PHIRE, PANCAID, PANCAIM
Approaches to early cancer diagnosis and the impact of artificial intelligence in oncology

Register for our webinar
15 October 2025
14:00 - 15:00 CEST
Registration link: https://events.teams.microsoft.com/event/1fba7a3a-b605-4bcd-9b99-2076044436a7@ea8b78d9-ccc1-45ec-94de-369c8af49a53

More information: https://pancaid-project.eu/news-events/events/

Funded by the European Union
pancaid.bsky.social
🧠 How is AI transforming early cancer detection? 
Join @phireproject.bsky.social, @pancaid.bsky.social, and #PANCAIM on 15 October, 14:00 CEST for a 60-min webinar. 
🔗 Register: https://tinyurl.com/PPPWebinarOnAI 
 
#AI #CancerDiagnosis #Webinar
pancaid.bsky.social
🚨 New PANCAID Masterclass!
How is #AI transforming pancreatic cancer research?
Dr Núria Malats & Sergio Sabroso (CNIO) explain its role in early detection and #precisiononcology.

▶️ https://youtu.be/H-_Xv3H7fZI
@nuriamalats.bsky.social @cniostopcancer.bsky.social 

#CancerResearch #PancreaticCancer
pancaid.bsky.social
🎙️Join us for the webinar “Approaches to Early Cancer Diagnosis & the Impact of #AIinOncology” 
🗣️ Moderated by Federica Zanca, EIC Programme Manager 
👥 Panelists: 
@phireproject.bsky.social – Massimo Alfano 
@pancaid.bsky.social  – @nuriamalats.bsky.social 
#PANCAIM – John Hermans 

#Webinar
pancaid.bsky.social
Join our webinar “Approaches to Early Cancer Diagnosis and the Impact of Artificial Intelligence in Oncology”!
@phireproject.bsky.social, #PANCAIM & @pancaid.bsky.social are proud to discuss how AI is transforming #oncology.

🔗 Register: events.teams.microsoft.com/event/1fba7a...

#CancerResearch
PHIRE, PANCAID, PANCAIM
Approaches to early cancer diagnosis and the impact of artificial intelligence in oncology

Register for our webinar
15 October 2025
14:00 - 15:00 CEST
Registration link: https://events.teams.microsoft.com/event/1fba7a3a-b605-4bcd-9b99-2076044436a7@ea8b78d9-ccc1-45ec-94de-369c8af49a53

More information: https://pancaid-project.eu/news-events/events/

Funded by the European Union
Reposted by PANCAID
maloehr.bsky.social
@pancaid.bsky.social is testing the best #liquidbiopsy for the early detection of #pancreaticcancer! Proud to be part of it @ki.se @hpb-karolinska.bsky.social
pancaid.bsky.social
It’s #RNAday! RNA, especially #microRNA, plays an important role in our research: Part of WP2 is profiling multi-omics data, where we analyse genomic, epigenomic, transcriptomic, microRNA and metabolomic data from #PDAC patients. #pancreaticcancer
➡️ https://pancaid-project.eu/research/work-packages/
pancaid.bsky.social
🚀 Partner spotlight: @zavamed.bsky.social
Leading telehealth platform ensure the readiness for a digital end-to-end patient pathway.
Contributing to:
📍 WP1 – Patient cohort definition & biomaterial collection
📍 WP6 – Dissemination & communication

#HorizonEurope #DigitalHealth #Telemedicine
pancaid.bsky.social
It’s #RNAday! RNA, especially #microRNA, plays an important role in our research: Part of WP2 is profiling multi-omics data, where we analyse genomic, epigenomic, transcriptomic, microRNA and metabolomic data from #PDAC patients. #pancreaticcancer
➡️ https://pancaid-project.eu/research/work-packages/
Reposted by PANCAID
maloehr.bsky.social
Plus we are analysing samples from #pancreaticcancer patients for #extracellularvesicles #EV @danielhagey
pancaid.bsky.social
🔬 This week’s #PANCAID partner spotlight: @regionstockholm.bsky.social (RS)!

RS contributes to WP1 via Karolinska University Hospital, working with Prof. Löhr's group on clinical recruitment & biobanking.

@hpb-karolinska.bsky.social
@maloehr.bsky.social
@ki.se

#HorizonEurope #CancerResearch
pancaid.bsky.social
🔬 This week’s #PANCAID partner spotlight: @regionstockholm.bsky.social (RS)!

RS contributes to WP1 via Karolinska University Hospital, working with Prof. Löhr's group on clinical recruitment & biobanking.

@hpb-karolinska.bsky.social
@maloehr.bsky.social
@ki.se

#HorizonEurope #CancerResearch
pancaid.bsky.social
🔦 #PANCAIDPartnerSpotlight: The University of Cambridge (via @cruk-ci.bsky.social) powers WP2 & WP3, and contributes expertise in circulating tumour DNA (ctDNA) analysis and multi-omic data integration.

#CancerResearch #PancreaticCancer #EarlyDetection
pancaid.bsky.social
🔦 #PANCAIDPartnerSpotlight: FIBIRYCIS brings expertise in #LiquidBiopsy, cancer genetics & PDAC biomarkers to WP1 – supporting sample & data collection across pancreatic lesions.

Part of the Ramón y Cajal Health Research Institute.

#CancerResearch #PancreaticCancer #EarlyDetection
pancaid.bsky.social
🔦 This week’s #PANCAIDPartnerSpotlight: KSM Innovation / MACCABI

KSM's strengths are:
📊 Access to 30+yrs of digital health data from 2.7M members
🧬 900K biobank samples

In PANCAID, they contribute to WP1 by providing blood samples

#HealthData #CancerDetection #Biobank
pancaid.bsky.social
🔦 PANCAID Partner Spotlight: @collectiveminds.bsky.social
Co-Leading WP3: Data management & AI 🔍
CMR powers our secure, multimodal data infrastructure:
📊 Repository design
🔐 Privacy & governance

#PANCAID #DataManagement #CancerResearch
pancaid.bsky.social
🔦 PANCAID Partner Spotlight: @hebrewuniversity.bsky.social
The Dor & Kaplan labs lead epigenetic and ML innovation for PANCAID.

🔬 Dor Group: cfDNA tissue-of-origin via DNA methylation
🧠 Kaplan Group: Multi-omics modeling with advanced machine learning

#CancerDetection #PancreaticCancer
pancaid.bsky.social
PANCAID is proud to share that coordinator Klaus Pantel will speak at the G7 Cancer conference in Paris on June 26.
🕚 11:50 AM
💬 Talk: Early diagnosis and detection of minimally residual disease in #pancreaticcancer using #liquidbiopsy

More info: g7cancer-events.com

#G7Cancer
PANCAID coordinator Prof. Klaus Pantel will speak at the G7 Cancer Conference on Poor Prognosis Cancers in Paris, France, on 26th June 2025
More information at g7cancer-events.com
pancaid.bsky.social
🔦 PANCAID Partner Spotlight: @uu.se
The labs of @masoodkamali.bsky.social & @globischlab.bsky.social bring cutting-edge EV, proteomics & metabolomics expertise to PANCAID.
🟣 Working together on biomarker discovery in WP2.

@scilifelab.se
#Metabolomics #CancerResearch
pancaid.bsky.social
🔦 PANCAID Partner Spotlight: University Hospital Heidelberg (UKHD)
UKHD’s European Pancreas Center (EPZ) provides key biosamples & serum proteomics for PANCAID.
With 10k+ samples in PancoBank, their biobank is critical to early detection research.
#PancreaticCancer #Proteomics
pancaid.bsky.social
📢 New review from PANCAID's WP4: Cost-effectiveness of #earlydetection in #pancreaticcancer 🧾💶
➡️ Some strategies work well, but inconsistencies in methods limit broader conclusions.

Read the full paper: link.springer.com/article/10.1...

@drchrisbrett.bsky.social
#HealthEconomics
pancaid.bsky.social
🧠 Midpoint check-in!
Today, PANCAID held its 6th Steering Committee meeting as we hit the halfway mark of our #HorizonEU project.
WP leads aligned strategy & next steps for advancing early #PancreaticCancer detection.
We’re buzzing for what’s ahead! ⚡

#CancerResearch #LiquidBiopsy
pancaid.bsky.social
🔦 PANCAID Partner Spotlight: CHU de Montpellier
At LCCRH, CHUM pioneers CTC research to drive early cancer detection.
They support WP2, WP3 & WP6: from biomarker discovery to data science and training young researchers.
@cathiepana.bsky.social

#LiquidBiopsy #CancerResearch #PancreaticCancer
pancaid.bsky.social
Today is #WorldDigestiveHealthDay 🟣
PANCAID aims to tackle one of the biggest challenges in digestive health: the late detection of #PancreaticCancer.
We're working on a minimally invasive blood test to catch it early, when it’s still treatable.

#EarlyDetection #CancerResearch
pancaid.bsky.social
🧬 New research: Fecal #metabolomics reveals key differences between autoimmune & chronic pancreatitis, unlocking potential for novel diagnostics!
📄 Read the study: onlinelibrary.wiley.com/doi/full/10....

@maloehr.bsky.social @globischlab.bsky.social

#PancreaticCancer #Biomarkers #liquidbiopsy
pancaid.bsky.social
🔦 PANCAID Partner Spotlight: #UKSH
UKSH co-leads WP1 in PANCAID: Defining patient cohorts & guiding biomaterial collection.
With 650+ cancer & 100+ control samples from TRIBanK, they power biomarker discovery for early #pancreaticcancer detection.
@sebens-iet-kiel.bsky.social
pancaid.bsky.social
PANCAID Coordinator Prof. Klaus Pantel joins a high-level seminar on #PrecisionDiagnostics & NGS in cancer care, hosted by MEP Vlad Voiculescu, organised by #Instand-NGS4P

The message: We need to accelerate access to innovative diagnostics like #LiquidBiopsy for every patient in 🇪🇺.
Poster of High Level Seminar on Precision Diagnostics for Precision Cancer Care.
Subline: Improving Patient Access to Innovation

Hosted by MEP Vasile (Vlad) Voiculescu

European Parliament - Brussels
Room SPAAK 7C50
May 20th, 2025 - 14:00 - 18:00

Organised by EU-funded project Instand-NGS4P